Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104

Condition:   Chronic Hepatitis b Interventions:   Drug: ISA104;   Drug: Placebo Sponsors:   Erasmus Medical Center;   ISA Pharmaceuticals B.V. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials